Command Palette

Search for a command to run...

Parmax Pharma Ltd.
31.8(+0.95%)
1W: +0.10%

Parmax Pharma Peer Comparison

Snapshot Summary

In the Pharmaceuticals & Drugs sector, Parmax Pharma Ltd. significantly underperforms compared to its peers, showing no revenue growth or profitability metrics. Companies like Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. emerge as strong leaders with impressive growth rates and profitability, while Parmax Pharma remains financially weak, indicating a high-risk investment.

  • • Parmax Pharma Ltd. shows no revenue growth, negative PE, and zero ROE, indicating financial weakness.
  • • Sun Pharmaceutical Industries and Dr. Reddy's Laboratories are sector leaders in profitability and growth.
  • • Companies with low valuation metrics like Cipla Ltd. are strong value picks despite higher PE ratios.
  • • Sun Pharmaceutical Industries Ltd.: Strong growth with 8.42% YoY revenue growth and 20.85% profit margin.
  • • Dr. Reddy's Laboratories Ltd.: High profitability with a 21.76% ROE and 16.54% YoY revenue growth.
  • • Mankind Pharma Ltd.: Excellent growth trajectory with 18.12% YoY revenue growth and high ROE.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Parmax Pharma Ltd.₹35.31₹13.21Cr-6.31--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.

Explore
Watchlists